Insights On Pharmaceutical Logistics
-
Key Takeaways Of Annex 1: What It Means For Your Cold Chain Management
10/19/2023
What are the practical implications of the latest Annex 1 update, specifically for cold chain management?
-
Societalâ„¢ CDMO Capacity Update June 2023: Small Molecule
6/21/2023
Societal is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market.
-
Uninterrupted Supply To Meet Demand
1/23/2024
Explore a solution for biopharmaceutical companies concerned about the risks an increase in campaign volume can pose to their production timeline.
-
Over The Hurdles: Taking Psychedelics From Schedule I To Pharmacy
10/12/2023
Learn how a partner with experience in handling scheduled substances and navigating FDA and DEA regulation can help you advance toward clinical research and drug development with ease.
-
File First In Europe, Then The U.S.?
10/24/2023
Karla Knower, Global Head of Regulatory Affairs, Paradigm Biopharmaceuticals, answers a challenging question from an attendee at a recent Outsourced Pharma Live.
-
Key Cleanroom Design Considerations For Drug Manufacturing
4/18/2023
Compare and contrast the pros and cons of several cleanroom design and construction methods to determine the most suitable approach for your specific project.
-
Cold Chain Logistics And Packaging Considerations For Probiotics
7/5/2023
Choosing the right packaging partner for your probiotic may be the most crucial step to ensuring your product is safe and potent when it reaches the consumer.
-
Transitioning From Using RUO To cGMP Chemicals For Clinical Trials
10/17/2023
Learn about the common challenges and risks associated with accelerating your molecule's timeline from lab to clinic, along with important supply chain considerations for emerging biopharma companies.
-
Risk Mitigation For Late-Stage Clinical Assets
10/9/2023
Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering.
-
End-To-End Cold Chain Management: A Next-Generation Approach
2/26/2024
Three experts in cold chain management walk through the advantages of end-to-end platforms for bulk drug substance management.